Palynziq 2.5 mg in 0.5 mL Prefilled Syringe
RxNorm 2046376
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2046376 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Palynziq 2.5 mg in 0.5 mL Prefilled Syringe.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
0.5 mL Palynziq 5 mg/ML Prefilled Syringe
(Atom ID: 10274496)
SBDPrescribable
Semantic Branded Drug (SBD):
0.5 mL pegvaliase-pqpz 5 mg/ML Prefilled Syringe [Palynziq]
(Atom ID: 10274494)
PSNPrescribable
Prescribable Name (PSN):
Palynziq 2.5 mg in 0.5 mL Prefilled Syringe
(Atom ID: 10274495)
SYPrescribable
Synonym (SY):
Palynziq 2.5 mg per 0.5 mL Prefilled Syringe
(Atom ID: 10274497)
Patient Education
Pegvaliase-pqpz Injection
Pegvaliase-pqpz injection is used along with a specific diet to reduce blood phenylalanine levels in people who have phenylketonuria (PKU; an inborn condition in which phenylalanine may build up in the blood and causes decreased intelligence and a decreased ability to focus, remember, and organize information) and who have uncontrolled blood phenylalanine levels. Pegvaliase-pqpz injection is in a class of medications called enzymes. It works by helping to reduce the amount of phenylalanine in the body.
[Learn More]
* Please review the disclaimer below.